Follow
D. Michael Ando
D. Michael Ando
Verified email at google.com
Title
Cited by
Cited by
Year
In silico labeling: predicting fluorescent labels in unlabeled images
EM Christiansen, SJ Yang, DM Ando, A Javaherian, G Skibinski, S Lipnick, ...
Cell 173 (3), 792-803. e19, 2018
5812018
Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models
SJ Barmada, A Serio, A Arjun, B Bilican, A Daub, DM Ando, A Tsvetkov, ...
Nature chemical biology 10 (8), 677-685, 2014
4452014
Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy
A Serio, B Bilican, SJ Barmada, DM Ando, C Zhao, R Siller, K Burr, ...
Proceedings of the National Academy of Sciences 110 (12), 4697-4702, 2013
3922013
Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration
AS Tsvetkov, M Arrasate, S Barmada, DM Ando, P Sharma, BA Shaby, ...
Nature chemical biology 9 (9), 586-592, 2013
1862013
Assessing microscope image focus quality with deep learning
SJ Yang, M Berndl, D Michael Ando, M Barch, A Narayanaswamy, ...
BMC bioinformatics 19, 1-9, 2018
1592018
Nrf2 mitigates LRRK2-and α-synuclein–induced neurodegeneration by modulating proteostasis
G Skibinski, V Hwang, DM Ando, A Daub, AK Lee, A Ravisankar, ...
Proceedings of the National Academy of Sciences 114 (5), 1165-1170, 2017
1112017
The RNA-binding Protein TDP-43 Selectively Disrupts MicroRNA-1/206 Incorporation into the RNA-induced Silencing Complex*♦
IN King, V Yartseva, D Salas, A Kumar, A Heidersbach, DM Ando, ...
Journal of Biological Chemistry 289 (20), 14263-14271, 2014
862014
Improving phenotypic measurements in high-content imaging screens
DM Ando, CY McLean, M Berndl
BioRxiv, 161422, 2017
772017
No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro
DW Peterson, DM Ando, DA Taketa, H Zhou, FW Dahlquist, J Lew
Proceedings of the National Academy of Sciences 107 (7), 2884-2889, 2010
632010
High-throughput screening in primary neurons
P Sharma, DM Ando, A Daub, JA Kaye, S Finkbeiner
Methods in enzymology 506, 331-360, 2012
592012
A machine learning approach to define antimalarial drug action from heterogeneous cell-based screens
GW Ashdown, M Dimon, M Fan, F Sánchez-Román Terán, K Witmer, ...
Science advances 6 (39), eaba9338, 2020
402020
Morphological profiling of tubercle bacilli identifies drug pathways of action
TC Smith, KM Pullen, MC Olson, ME McNellis, I Richardson, S Hu, ...
Proceedings of the National Academy of Sciences 117 (31), 18744-18753, 2020
302020
JUMP Cell Painting dataset: morphological impact of 136,000 chemical and genetic perturbations
SN Chandrasekaran, J Ackerman, E Alix, DM Ando, J Arevalo, M Bennion, ...
Biorxiv, 2023.03. 23.534023, 2023
282023
Automated robotic microscopy systems
SM Finkbeiner, DM Ando, AC Daub
US Patent 10,474,920, 2019
232019
Automated detection and staging of malaria parasites from cytological smears using convolutional neural networks
MS Davidson, C Andradi-Brown, S Yahiya, J Chmielewski, AJ O’Donnell, ...
Biological imaging 1, e2, 2021
222021
Applying deep neural network analysis to high-content image-based assays
SJ Yang, SL Lipnick, NR Makhortova, S Venugopalan, M Fan, ...
SLAS DISCOVERY: Advancing Life Sciences R&D 24 (8), 829-841, 2019
222019
Batch equalization with a generative adversarial network
WW Qian, C Xia, S Venugopalan, A Narayanaswamy, M Dimon, ...
Bioinformatics 36 (Supplement_2), i875-i883, 2020
162020
Physics-enhanced machine learning for virtual fluorescence microscopy
CL Cooke, F Kong, A Chaware, KC Zhou, K Kim, R Xu, DM Ando, ...
Proceedings of the IEEE/CVF International Conference on Computer Vision …, 2021
132021
Longitudinal imaging and analysis of neurons expressing polyglutamine-expanded proteins
AS Tsvetkov, DM Ando, S Finkbeiner
Tandem Repeats in Genes, Proteins, and Disease: Methods and Protocols, 1-20, 2013
122013
Analysis of perturbed subjects using semantic embeddings
DM Ando, M Berndl, L Yang, M Dimon
US Patent 10,769,501, 2020
92020
The system can't perform the operation now. Try again later.
Articles 1–20